PT Merck Tbk (MERK.JK)
IDR 3580.0
(0.85%)
IDR 3580.0
(0.85%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 199.72 Billion IDR | -16.56% |
| 2022 | 239.07 Billion IDR | 24.83% |
| 2021 | 191.52 Billion IDR | 76.47% |
| 2020 | 108.53 Billion IDR | -13.58% |
| 2019 | 125.59 Billion IDR | 166.49% |
| 2018 | 47.12 Billion IDR | -77.4% |
| 2017 | 208.49 Billion IDR | -2.25% |
| 2016 | 213.29 Billion IDR | 14.36% |
| 2015 | 186.51 Billion IDR | -6.95% |
| 2014 | 200.43 Billion IDR | -12.86% |
| 2013 | 230.02 Billion IDR | 62.85% |
| 2012 | 141.24 Billion IDR | -49.31% |
| 2011 | 278.62 Billion IDR | 80.29% |
| 2010 | 154.54 Billion IDR | -23.28% |
| 2009 | 201.45 Billion IDR | 43.74% |
| 2008 | 140.15 Billion IDR | 13.16% |
| 2007 | 123.85 Billion IDR | 3.61% |
| 2006 | 119.53 Billion IDR | 45.78% |
| 2005 | 81.99 Billion IDR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 37.32 Billion IDR | 66.33% |
| 2024 Q2 | 23.65 Billion IDR | -16.35% |
| 2024 Q1 | 28.27 Billion IDR | -8.08% |
| 2023 FY | 199.48 Billion IDR | -16.56% |
| 2023 Q4 | 30.75 Billion IDR | -41.78% |
| 2023 Q3 | 52.83 Billion IDR | -10.65% |
| 2023 Q2 | 59.12 Billion IDR | -0.4% |
| 2023 Q1 | 59.36 Billion IDR | 31.46% |
| 2022 Q3 | 36.55 Billion IDR | -52.06% |
| 2022 Q2 | 76.25 Billion IDR | -5.97% |
| 2022 Q1 | 81.1 Billion IDR | 123.43% |
| 2022 FY | 239.07 Billion IDR | 24.83% |
| 2022 Q4 | 45.15 Billion IDR | 23.52% |
| 2021 FY | 191.52 Billion IDR | 76.47% |
| 2021 Q1 | 68.96 Billion IDR | 104.34% |
| 2021 Q2 | 38.22 Billion IDR | -44.58% |
| 2021 Q3 | 48.04 Billion IDR | 25.69% |
| 2021 Q4 | 36.29 Billion IDR | -24.45% |
| 2020 FY | 108.53 Billion IDR | -13.58% |
| 2020 Q2 | 2.84 Billion IDR | -92.93% |
| 2020 Q4 | 33.75 Billion IDR | 6.34% |
| 2020 Q1 | 40.2 Billion IDR | -57.64% |
| 2020 Q3 | 31.73 Billion IDR | 1016.62% |
| 2019 FY | 125.59 Billion IDR | 166.49% |
| 2019 Q1 | 15.67 Billion IDR | 110.95% |
| 2019 Q2 | -3.49 Billion IDR | -122.26% |
| 2019 Q3 | 18.49 Billion IDR | 629.8% |
| 2019 Q4 | 94.91 Billion IDR | 413.33% |
| 2018 Q3 | 66.41 Billion IDR | 25.11% |
| 2018 Q2 | 53.08 Billion IDR | -25.01% |
| 2018 FY | 47.12 Billion IDR | -77.4% |
| 2018 Q1 | 70.78 Billion IDR | 2879.24% |
| 2018 Q4 | -143.15 Billion IDR | -315.56% |
| 2017 Q2 | 48.46 Billion IDR | -45.24% |
| 2017 FY | 208.49 Billion IDR | -2.25% |
| 2017 Q4 | 2.37 Billion IDR | -96.56% |
| 2017 Q3 | 69.16 Billion IDR | 42.73% |
| 2017 Q1 | 88.49 Billion IDR | 94.84% |
| 2016 FY | 213.29 Billion IDR | 14.36% |
| 2016 Q1 | 79.2 Billion IDR | 158.72% |
| 2016 Q2 | 49.82 Billion IDR | -37.09% |
| 2016 Q3 | 38.85 Billion IDR | -22.01% |
| 2016 Q4 | 45.41 Billion IDR | 16.89% |
| 2015 Q1 | 64.59 Billion IDR | 345.92% |
| 2015 Q2 | 50.6 Billion IDR | -21.66% |
| 2015 Q3 | 40.69 Billion IDR | -19.58% |
| 2015 Q4 | 30.61 Billion IDR | -24.78% |
| 2015 FY | 186.51 Billion IDR | -6.95% |
| 2014 FY | 200.43 Billion IDR | -12.86% |
| 2014 Q1 | 79.89 Billion IDR | 211.58% |
| 2014 Q2 | 52.23 Billion IDR | -34.62% |
| 2014 Q4 | 14.48 Billion IDR | -73.08% |
| 2014 Q3 | 53.82 Billion IDR | 3.04% |
| 2013 FY | 230.02 Billion IDR | 62.85% |
| 2013 Q4 | 25.64 Billion IDR | -45.26% |
| 2013 Q3 | 46.84 Billion IDR | -3.92% |
| 2013 Q2 | 48.75 Billion IDR | -55.18% |
| 2013 Q1 | 108.78 Billion IDR | 53488.41% |
| 2012 Q2 | 54.45 Billion IDR | 8.0% |
| 2012 Q4 | -203.76 Million IDR | -100.56% |
| 2012 FY | 141.24 Billion IDR | -49.31% |
| 2012 Q1 | 50.42 Billion IDR | -56.78% |
| 2012 Q3 | 36.57 Billion IDR | -32.83% |
| 2011 FY | 278.62 Billion IDR | 80.29% |
| 2011 Q3 | 46.23 Billion IDR | -16.58% |
| 2011 Q2 | 55.42 Billion IDR | -5.98% |
| 2011 Q1 | 58.95 Billion IDR | 70.08% |
| 2011 Q4 | 116.66 Billion IDR | 152.32% |
| 2010 Q4 | 34.66 Billion IDR | 0.0% |
| 2010 FY | 154.54 Billion IDR | -23.28% |
| 2010 Q1 | 53.68 Billion IDR | 11.62% |
| 2009 FY | 201.45 Billion IDR | 43.74% |
| 2009 Q4 | 48.09 Billion IDR | 0.0% |
| 2009 Q1 | 53.68 Billion IDR | 0.0% |
| 2008 FY | 140.15 Billion IDR | 13.16% |
| 2007 FY | 123.85 Billion IDR | 3.61% |
| 2006 FY | 119.53 Billion IDR | 45.78% |
| 2005 FY | 81.99 Billion IDR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 190.05 Billion IDR | -5.093% |
| PT Phapros, Tbk | 71.32 Billion IDR | -180.044% |
| PT Pyridam Farma Tbk | 1.87 Billion IDR | -10526.787% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 1190.87 Billion IDR | 83.228% |
| PT Tempo Scan Pacific Tbk | 1257.95 Billion IDR | 84.123% |